Paclitaxel derivative-based liposomal nanoplatform for potentiated chemo-immunotherapy

The combination of chemotherapy with the immune checkpoint blockade (ICB) therapy is bringing a tremendous hope in the treatment of malignant tumors. However, the treatment efficacy of the existing chemo-immunotherapy is not satisfactory due to the high cost and immunogenicity of ICB antibodies, low...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of controlled release 2022-01, Vol.341, p.812-827
Hauptverfasser:	Wang, Yingli, Yu, Jiang, Li, Dan, Zhao, Liwen, Sun, Bingjun, Wang, Jiamei, Wang, Zhenjie, Zhou, Shuang, Wang, Menglin, Yang, Yinxian, Liu, Hongzhuo, Zhang, Haotian, Lv, Qingzhi, Jiang, Qikun, He, Zhonggui, Wang, Yongjun
Format:	Artikel
Sprache:	eng
Schlagworte:	Chemo-immunotherapy Co-loaded liposomes Immune checkpoint blockade Paclitaxel derivative Remote-loading
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!